A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be ...

COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic ...

Panelists discuss key advice for patients and caregivers navigating advanced prostate cancer, highlighting essential insights ...

Panelists discuss the key takeaways from their experiences in treating advanced prostate cancer, emphasizing valuable lessons ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...

Survivorship: it’s a positive word that elicits the idea of success, winning and, as a four-time cancer survivor myself, the ...

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

Maria Hicinbothem, Wandaris Ortiz, and Sandi Wetherbee—are being celebrated for their exceptional dedication to patient care, ...

When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...